23andMe Wants to Develop Drugs Based On Your DNA

☞ | View the text of this post. Exclusively available to ASQ Members.

The company popularizing at-home saliva kits just received a massive investment to further develop drugs based on user DNA.

23andMe, a genetics testing startup, announced on Tuesday it banked a $250 million funding round from Sequoia Capital. The Silicon Valley venture capitalist firm has backed companies like Google, Instagram, and Airbnb.

The company is most known for collecting the spit of customers in exchange for information about their genetic history, health, and physical traits based on their

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *